1. Nuclear Pore Complex: The nuclear pore complex (NPC) is a large protein structure that controls the movement of molecules between the cytoplasm and the nucleus. It acts as a selective barrier, allowing the passage of certain molecules while blocking others. HIV DNA is too large to passively diffuse through the NPC, and specific transport mechanisms are required for its entry.
2. TRIM5α: TRIM5α is a cellular protein that plays a critical role in blocking HIV infection. It belongs to the tripartite motif (TRIM) family of proteins and is found in the cytoplasm of cells. TRIM5α binds to the HIV capsid, which encapsulates the viral RNA genome, and prevents the uncoating of the viral core. By maintaining the integrity of the capsid, TRIM5α blocks the release of HIV DNA into the cytoplasm and subsequent entry into the nucleus.
3. Cyclophilin A: Cyclophilin A (CypA) is a host cell protein that is incorporated into the HIV virion during viral assembly. CypA interacts with the HIV capsid and facilitates the uncoating process, allowing the release of viral RNA into the cytoplasm. However, some polymorphisms in the CypA gene confer resistance to HIV infection by impairing the interaction between CypA and the viral capsid. This prevents the uncoating of the virus and blocks the entry of HIV DNA into the cell nucleus.
4. LEDGF/p75: Lens epithelium-derived growth factor (LEDGF/p75) is a cellular protein that interacts with the HIV integrase enzyme. Integrase is responsible for integrating the viral DNA into the host cell genome, a critical step in the viral life cycle. LEDGF/p75 normally tethers integrase to the chromatin, facilitating the integration process. However, some LEDGF/p75 isoforms can interfere with the interaction between integrase and the chromatin, thereby inhibiting the integration of HIV DNA into the host genome.
5. APOBEC3 Proteins: APOBEC3 proteins are a family of cellular enzymes that can deaminate cytidine to uridine in DNA and RNA molecules. APOBEC3G, in particular, is known to inhibit HIV infection by deaminating the viral DNA during reverse transcription, the process by which the viral RNA genome is converted into DNA. By introducing errors into the viral DNA, APOBEC3G compromises the integrity of the viral genome and prevents its integration into the host cell chromosome.
These cellular defense mechanisms collectively act as barriers to block the entry of HIV DNA into the cell nucleus, limiting the virus's ability to establish infection and replicate. Understanding these mechanisms is crucial for developing novel therapeutic strategies to combat HIV infection.
